Cargando…
Renal consequences of the novel coronavirus disease 2019 (COVID-19) and hydrogen sulfide as a potential therapy
The novel coronavirus disease 2019 (COVID-19), caused by SARS-CoV-2, is a global pandemic which is primarily considered a respiratory illness. However, emerging reports show that the virus exhibits both pulmonary and extra-pulmonary manifestations in humans, with the kidney as a major extra-pulmonar...
Autores principales: | Dugbartey, George J., Alornyo, Karl K., Ohene, Bright O., Boima, Vincent, Antwi, Sampson, Sener, Alp |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8755416/ https://www.ncbi.nlm.nih.gov/pubmed/35032641 http://dx.doi.org/10.1016/j.niox.2022.01.002 |
Ejemplares similares
-
Hydrogen Sulfide Metabolite, Sodium Thiosulfate: Clinical Applications and Underlying Molecular Mechanisms
por: Zhang, Max Y., et al.
Publicado: (2021) -
Pre-Treatment of Transplant Donors with Hydrogen Sulfide to Protect against Warm and Cold Ischemia-Reperfusion Injury in Kidney and Other Transplantable Solid Organs
por: McFarlane, Liam, et al.
Publicado: (2023) -
Targeting hepatic sulfane sulfur/hydrogen sulfide signaling pathway with α-lipoic acid to prevent diabetes-induced liver injury via upregulating hepatic CSE/3-MST expression
por: Dugbartey, George J., et al.
Publicado: (2022) -
Combination Therapy of Alpha-Lipoic Acid, Gliclazide and Ramipril Protects Against Development of Diabetic Cardiomyopathy via Inhibition of TGF-β/Smad Pathway
por: Dugbartey, George J., et al.
Publicado: (2022) -
The Optimization of Renal Graft Preservation Temperature to Mitigate Cold Ischemia-Reperfusion Injury in Kidney Transplantation
por: Abou Taka, Maria, et al.
Publicado: (2022)